Millie
your market intelligence analyst
Search Results
195 results
Your search is now limited to «Gilead» expert search.
NASDAQ 10/18/2019 11:17
Biotech major Gilead Sciences Inc. GILD is slated to report third-quarter 2019 results on Oct 24, after market close.
More from NASDAQ:
FierceBiotech 10/18/2019 10:36
Gilead, Spring Bank’s Hep B combo shows ‘incremental benefit,’ but all eyes on higher doses: analysts.
More from FierceBiotech:
24/7 Wall Street 10/17/2019 09:14
Thursday's top analyst upgrades, downgrades and initiations for Thursday included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and...
More from 24/7 Wall Street:
PMLiVE 10/17/2019 05:43
Gilead acquired the rights to Kite’s CAR-T therapy Yescarta (axicabtagene ciloleucel) for lymphoma in that deal – however, the drug continues to fall short of analyst expectations, bringing in $264m last year, while Gilead paid almost $12bn for the company in 2017 ...
More from PMLiVE:
Pharmafile 10/16/2019 07:46
Published on: 16/10/19 Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November.
More from Pharmafile:
Xconomy 10/15/2019 12:31
Glenmark Pharmaceuticals, which has made generic drugs for about four decades, on Tuesday formally spun off its drug R&D unit as an independent business aiming to advance a handful of novel molecules the Indian company has developed in recent years. The new company, called Ichnos Sciences, emerges with a clinical-stage pipeline that has experimental treatments […]
More from Xconomy:
FiercePharmaManufacturing 10/15/2019 11:01
Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it.
More from FiercePharmaManufacturing:
ENDPOINTS 10/15/2019 09:55
After gaining credit as the architect of Gilead’s $12 billion Kite buyout as well as the recent $5 billion partnership with Galapagos, new CEO Daniel O’Day is promoting chief strategy officer Andrew Dickinson to the prestigious CFO post at the big biotech.
More from ENDPOINTS:
Business Wire 10/15/2019 08:30
Mr. Dickinson joined Gilead in 2016 and has transformed the way that the company approaches corporate development, expanding the kinds of transactions executed and implementing a broader and more strategic approach to deal-making.
More from Business Wire:
Balm of Gilead Salve has the compounds that come exactly as found in the fresh herbs of Balm of Gilead, St. John's Wort and Arnica.
More from Middle East North Africa Financial Network (MENAFN):
Gilead plans to file a New Drug Application (NDA) for filgotinib for the treatment of rheumatoid arthritis in the United States including the FINCH 1 and FINCH 3 Week 52 data later this year.
More from Pharmaceutical Business Review:
InPharmaTechnologist 10/07/2019 10:56
... Truvada’s high efficacy with statistically significant improvements in renal and bone safety, which can be an important consideration as people at risk increasingly use PrEP for longer periods of time,” said Daniel O’Day, CEO at Gilead Sciences.
More from InPharmaTechnologist:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications